Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review in: European Journal of Endocrinology Volume 181 Issue 3 (2019)
How Immunotherapy Could Stop and Prevent Type 1 Diabetes
Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes
Immunotherapy: Building a bridge to a cure for type 1 diabetes | Science
Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes
Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes | Nature Reviews Immunology
Frontiers | Peptide Immunotherapy for Type 1 Diabetes—Clinical Advances
Approaches in the Treatment of Type 1 Diabetes Mellitus | EMJ Reviews
Diabetology | Free Full-Text | Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes
A Question of Tolerance—Antigen-Specific Immunotherapy for Type 1 Diabetes | SpringerLink
A cancer immunotherapy technique may prevent diabetes
Investigating the Side Effects of Cancer Immunotherapy - NCI
Antigen-specific therapy against Type 1 diabetes: mechanisms and perspectives | Immunotherapy
Immune Mechanisms and Pathways Targeted in Type 1 Diabetes | SpringerLink
Retraining the immune system to fight type 1 diabetes | Diabetes UK
Diabetic ketoacidosis following immunotherapy for lung cancer | Tidsskrift for Den norske legeforening
Immune checkpoint inhibitor diabetes mellitus: a novel form of autoimmune diabetes - Quandt - 2020 - Clinical & Experimental Immunology - Wiley Online Library
Immunotherapy and Diabetes: A Game of Hide and Seek? - ResOU
Immunotherapy in Autoimmune Type 1 Diabetes | The Review of Diabetic Studies
Imcyse's Type 1 Diabetes Immunotherapy Shows Promise in Phase I